|
BCORL1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.130400E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.354000E-02 |
| Normal-vs-Stage2 |
2.830400E-01 |
| Normal-vs-Stage3 |
2.730800E-01 |
| Normal-vs-Stage4 |
6.619200E-01 |
| Stage1-vs-Stage2 |
8.036000E-01 |
| Stage1-vs-Stage3 |
7.260700E-03 |
| Stage1-vs-Stage4 |
8.759400E-01 |
| Stage2-vs-Stage3 |
9.369500E-02 |
| Stage2-vs-Stage4 |
9.665200E-01 |
| Stage3-vs-Stage4 |
2.874200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.793800E-01 |
| Normal-vs-AfricanAmerican |
1.686170E-01 |
| Normal-vs-Asian |
9.110000E-01 |
| Caucasian-vs-AfricanAmerican |
5.639400E-01 |
| Caucasian-vs-Asian |
8.549000E-01 |
| AfricanAmerican-vs-Asian |
6.936400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.734500E-02 |
| Normal-vs-Female |
3.552200E-01 |
| Male-vs-Female |
7.162700E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
8.623800E-02 |
| Normal-vs-Extreme_Weight |
2.901600E-02 |
| Normal-vs-Obese |
5.121200E-01 |
| Normal-vs-Extreme_Obese |
9.269800E-02 |
| Normal_Weight-vs-Extreme_Weight |
8.461800E-01 |
| Normal_Weight-vs-Obese |
5.491600E-02 |
| Normal_Weight-vs-Extreme_Obese |
7.493200E-01 |
| Extreme_Weight-vs-Obese |
1.500350E-02 |
| Extreme_Weight-vs-Extreme_Obese |
8.435600E-01 |
| Obese-vs-Extreme_Obese |
1.852770E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.416800E-01 |
| Normal-vs-Age(41-60Yrs) |
5.403000E-01 |
| Normal-vs-Age(61-80Yrs) |
4.619900E-03 |
| Normal-vs-Age(81-100Yrs) |
3.534000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.890200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.216000E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.622400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.427400E-04 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.161600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.868800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
3.527200E-01 |
| Normal-VS-Type2 PRCC |
1.277840E-01 |
| Normal-VS-KIRP CIMP |
3.542200E-01 |
| Normal-VS-Unclassified PRCC |
5.167400E-01 |
| Type1 PRCC-VS-Type2 PRCC |
3.606400E-01 |
| Type1 PRCC-VS-KIRP CIMP |
7.701000E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
1.701220E-01 |
| Type2 PRCC-VS-KIRP CIMP |
9.091600E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
9.170100E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
3.779800E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.060500E-03 |
| Normal-vs-N1 |
4.618800E-01 |
| Normal-vs-N2 |
1.629960E-01 |
| N0-vs-N1 |
4.005600E-02 |
| N0-vs-N2 |
1.013150E-01 |
| N1-vs-N2 |
9.368400E-02 |
|
|
